Heparin interference in anti-XA assays for rivaroxaban and apixaban

被引：0
|
作者：
Cutsforth, G. A. [1 ]
Finnegan, K. [2 ]
机构：
[1] Diagnostica Stago Inc, Vernon Hills, NJ USA
[2] SUNY Stony Brook, Stony Brook, NY 11794 USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO117-WED
引用
收藏
页码：795 / 795
页数：1
相关论文
共 50 条
  • [41] Accuracy of a Single, Heparin-Calibrated Anti-Xa Assay for the Measurement of Rivaroxaban, Apixaban, and Edoxaban Drug Concentrations: A Prospective Cross-Sectional Study
    Meihandoest, Tamana
    Studt, Jan-Dirk
    Mendez, Adriana
    Alberio, Lorenzo
    Fontana, Pierre
    Wuillemin, Walter A.
    Schmidt, Adrian
    Graf, Lukas
    Gerber, Bernhard
    Amstutz, Ursula
    Bovet, Cedric
    Sauter, Thomas C.
    Asmis, Lars M.
    Nagler, Michael
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [42] Apixaban and Rivaroxaban Anti-Xa Level Monitoring Versus Standard Monitoring in Hospitalized Patients With Acute Kidney Injury
    Towers, William
    Nguyen, Steffany N.
    Ruegger, Melanie C.
    Salazar, Eric
    Donahue, Kevin R.
    ANNALS OF PHARMACOTHERAPY, 2022, 56 (06) : 656 - 663
  • [43] Evaluation of a new anti-Xa heparin assay
    Davidson, S. J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 996 - 996
  • [44] CHRONOMETRIC DOSAGE OF AUTOMATIZED ANTI-XA HEPARIN
    MARQUESVERDIER, A
    RHALMI, N
    LAVENU, F
    GREZE, M
    COULET, M
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1985, 27 (02): : 112 - 112
  • [45] Effects of apixaban on prothrombin time, activated partial thromboplastin time and anti-Xa assays: a European survey
    Helin, Tuukka A.
    Pakkanen, Anja
    Lassila, Riitta
    Joutsi-Korhonen, Lotta
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2017, 55 (08) : E178 - E180
  • [46] Apixaban anti-Xa levels in clinical practice: A case report
    Clark, Sarah
    Alcala-Zermeno, Juan Luis
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024,
  • [47] DOAC-Remove to counteract the interference of anti-Xa oral anticoagulants on the monitoring of heparin
    Melicine, Sophie
    Habay, Capucine
    Ghammad, Wiame
    Carre, Julie
    Diehl, Jean Luc
    Smadja, David M.
    Gendron, Nicolas
    Helley, Dominique
    Mauge, Laetitia
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2024,
  • [48] Can an anti-Xa assay for low-molecular-weight heparin be used to assess the presence of rivaroxaban?
    Yates, Sean G.
    Smith, Sabra
    Tharpe, William
    Shen, Yu-Min
    Sarode, Ravi
    TRANSFUSION AND APHERESIS SCIENCE, 2016, 55 (02) : 212 - 215
  • [49] Anticoagulation assessment with prothrombin time and anti-XA assays in real-world patients on treatment with rivaroxaban
    Koenigsbruegge, O.
    Quehenberger, P.
    Belik, S.
    Weigel, G.
    Seger, C.
    Griesmacher, A.
    Pabinger, I
    Ay, C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 298 - 298
  • [50] Comparison Between Activated Partial Thromboplastin Time and Anti-Xa Heparin Assays on Patients on Unfractionated Heparin Therapy
    Pearlman, Eugene
    Bibars, Wafi
    Willard, Jennifer
    Moore, Darlene
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 : A127 - A127
12345